MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >
ASH Breakfast Symposium – Presentations Available Below

Breakfast Symposium Banner

Thank You!

Presentations are now available by clicking the links below…

Program Overview and Objectives
Peter Greenberg

Update of WHO and Molecular Classifications in MDS
Mario Cazzola

Therapeutic and Prognostic Role of Epigenetic Abnormalities in MDS
Stephen Nimer

Current Results of Alternative Conditioning Regimens and Donors for Allogeneic Hematopoietic Stem Cell Transplantation in MDS
Joachim Deeg

Impact of Comorbidity on Quality of Life and Clinical Outcomes in MDS
Peter Valent

Myeloid-derived Suppressor Cells and Altered Innate Immunity Contribution to MDS Pathogenesis
Alan List

Program Overview

Recent developments in clinical classification, epigenetic treatment and hematopoietic stem cell transplantation have generated valuable advances for aiding management of patients with myelodysplastic syndromes (MDS). Determining the impact of patient comorbidity and quality of life inform the use of these therapeutic approaches. These issues will be discussed as well as recent biologic data describing the role of altered marrow microenvironmental innate immunity involved in improved understanding of pathogenetic lesions underlying this disease.

Target Audience

This activity is intended for physicians, oncology nurses, nurse practitioners, physician assistants, pharmacists and other health care professionals interested in the treatment and management of patients with Myelodysplastic Syndromes.

Featured Faculty

Mario Cazzola, MD

Professor of Hematology
University of Pavia School of Medicine
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy

H. Joachim Deeg, MD

Professor of Medicine, University of Washington
Member, Fred Hutchinson Cancer Research Center
Seattle, WA

Peter Greenberg, MD

Professor of Medicine
Stanford University Cancer Center
Stanford, CA

Alan F. List, MD

President and CEO
Frank and Carol Morsani Endowed Chair
H. Lee Moffitt Cancer Center
and Research Institute
Tampa, Florida

Stephen D. Nimer, MD

Director, Sylvester Comprehensive Cancer Center
Professor of Medicine, Biochemistry & Molecular Biology
University of Miami Miller School of Medicine
Miami, Florida

Peter Valent, MD

Department of Internal Medicine I
Division of Hematology & Hemostaseology
Scientific Chair – Ludwig Boltzmann Cluster Oncology
Medical University of Vienna
Vienna, Austria




Review answers to commonly asked questions or get answers to your questions from an MDS expert